Details for New Drug Application (NDA): 204339
✉ Email this page to a colleague
The generic ingredient in RIZATRIPTAN BENZOATE is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.
Summary for 204339
Tradename: | RIZATRIPTAN BENZOATE |
Applicant: | Invagen Pharms |
Ingredient: | rizatriptan benzoate |
Patents: | 0 |
Pharmacology for NDA: 204339
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 204339
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 204339 | ANDA | RPK Pharmaceuticals, Inc. | 53002-1713 | 53002-1713-1 | 3 TABLET in 1 CARTON (53002-1713-1) |
RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 204339 | ANDA | DIRECT RX | 61919-394 | 61919-394-18 | 18 TABLET in 1 BLISTER PACK (61919-394-18) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Jul 1, 2013 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jul 1, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription